On Monday, Abeona Therapeutics Inc (NASDAQ: ABEO) opened higher 5.52% from the last session, before settling in for the closing price of $3.26. Price fluctuations for ABEO have ranged from $2.83 to $9.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -15.07% annually for the last half of the decade. Company’s average yearly earnings per share was noted 15.55% at the time writing. With a float of $25.91 million, this company’s outstanding shares have now reached $26.52 million.
In an organization with 84 employees, it is important to assess its efficiency.
Abeona Therapeutics Inc (ABEO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Abeona Therapeutics Inc is 5.27%, while institutional ownership is 52.12%. The most recent insider transaction that took place on Apr 26 ’24, was worth 24,764. In this transaction Director of this company bought 7,550 shares at a rate of $3.28, taking the stock ownership to the 78,323 shares. Before that another transaction happened on Apr 25 ’24, when Company’s Chief Executive Officer bought 10,000 for $3.20, making the entire transaction worth $32,000. This insider now owns 538,260 shares in total.
Abeona Therapeutics Inc (ABEO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 15.55% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Check out the current performance indicators for Abeona Therapeutics Inc (ABEO). In the past quarter, the stock posted a quick ratio of 4.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.59, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.90 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Let’s dig in a bit further. During the last 5-days, its volume was 2.43 million. That was better than the volume of 0.46 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 4.57%. Additionally, its Average True Range was 0.66.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 6.54%, which indicates a significant decrease from 7.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 317.49% in the past 14 days, which was higher than the 144.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.15, while its 200-day Moving Average is $5.04. However, in the short run, Abeona Therapeutics Inc’s stock first resistance to watch stands at $3.69. Second resistance stands at $3.94. The third major resistance level sits at $4.10. If the price goes on to break the first support level at $3.28, it is likely to go to the next support level at $3.12. Assuming the price breaks the second support level, the third support level stands at $2.87.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are currently 27,355K shares outstanding in the company with a market cap of 94.12 million. Presently, the company’s annual sales total 3,500 K according to its annual income of -54,190 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -11,840 K.
